Phase III KATHERINE Clinical Trial Crossed Early Reporting Boundary and Met its Primary Endpoint
Adjuvant T-DM1 improved invasive disease-free survival (IDFS) in patients with HER2-positive early breast cancer with residual invasive disease at...
Adjuvant T-DM1 improved invasive disease-free survival (IDFS) in patients with HER2-positive early breast cancer with residual invasive disease at...
Subgroup analysis suggested the treatment may benefit patients with nonbasal-like disease SAN ANTONIO Treating patients who had early-stage triple-negative...
PHILADELPHIA – A program that provided individually tailored lifestyle recommendations for patients undergoing screening for colorectal cancer helped encourage...
On behalf of the Board of Directors of the American Association for Cancer Research (AACR), and the 40,000 laboratory...
“The Pancreatic Cancer Collective, the strategic partnership of the Lustgarten Foundation and Stand Up To Cancer (SU2C), has awarded...
PHILADELPHIA – Patients who are diagnosed with adenomas, a possible precursor of colorectal cancer, often do not receive subsequent...
New restrictions aimed at halting and reversing the alarming rise in the use of e-cigarettes among youth WASHINGTON, D.C....
World’s leading cancer research experts from Philadelphia’s largest health care and academic institutions will unite for a live, interactive...
NEW ORLEANS – African-Americans caring for loved ones with cancer were less likely than their white peers to report...
NEW ORLEANS – Latinos in the United States experienced an overall increased risk of cancer death with each generation...